AngioDynamics (ANGO) Cash Flow Statement

Click line-items for a historical chart and %

Net income	1.3M
Depreciation and amortization	6.15M
Amortization of bond discounts and premiums
Tax effect on exercise of stock options and issuance of performance shares
Deferred income taxes	1.57M
Change in allowance for excess and obsolete inventory
Stock based compensation	1.68M
Change in accounts receivable allowances	-197K
Other	18K
Accounts receivable	2.82M
Inventories	-3.05M
Prepaid expenses and other	-869K
Accounts payable and accrued liabilities	-2.48M
Net cash provided by operating activities
Additions to property, plant and equipment	-481K
Proceeds from sale of assets
Purchases of marketable securities
Proceeds from sale or maturity of marketable securities
Net cash (used in) provided by investing activities
Repayment of long-term debt	-2.5M
Proceeds from exercise of stock options and employee stock purchase plan	2.8M
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents	-84K
Increase in cash and cash equivalents	5.08M
Cash and cash equivalents at beginning of period	32.33M
Cash and cash equivalents at end of period	37.41M

Entities mentioned with ANGO

View All Entities